Drug
Chop Cd4
Chop Cd4: highest development phase Phase 2, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| CHOP + CD4 NCT00893516 | Phase 2 | T-cell Lymphoma |
Latest
No recent events.
Follow Chop Cd4 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.